Trial Profile
Neoadjuvant Chemotherapy Versus Standard Treatment in Patients With Locally Advanced Colon Cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin
- Indications Colon cancer
- Focus Therapeutic Use
- Acronyms NeoCol
- 06 Jun 2023 Results assessing assess the impact of neoadjuvant chemotherapy on locally advanced colon cancer compared to standard initial surgery presented at the 59th Annual Meeting of the American Society of Clinical Oncology
- 27 Sep 2021 Status changed from recruiting to active, no longer recruiting.
- 21 Sep 2018 Planned End Date changed from 1 Aug 2019 to 1 Feb 2025.